GENIXUS Welcomes Two Biopharma Executives to its Growing Leadership Team
News provided by
Share this article
KANNAPOLIS, N.C., March 2, 2021 /PRNewswire/
GENIXUS, a pharmaceutical company focused on transforming acute and critical care medicines, today announced the addition of two new members to its executive team: Seth Coombs joins as Chief Commercial Officer and Don Anthony J.D. Ph.D. as Executive Vice President, Global Head of Intellectual Property. We are extremely fortunate to welcome Seth and Don to the GENIXUS team as we continue to build a leading essential medicines company, said
Kendall Foster, Founder & Chief Executive Officer of GENIXUS. Seth and Don each bring more than 20 years of critical experience in the Biopharma space. Their leadership, creativity, and passion for healthcare innovation are perfectly aligned with our mission to transform medicines within acute and critical care.